week 46 check-in — 21kg down, early fullness manageable, one thing confusing me
Check-in as promised in the title: week 46 check-in — 21kg down, early fullness manageable, one thing confusing me.
The relevant figures are week 46 and 21kg, and they come from the same log I have kept the whole time.
It is a dual GIP and GLP-1 receptor agonist, and the GIP arm is the part that has no equivalent in the semaglutide threads. That is why the side-effect profile reads differently rather than just milder.
Weekly dosing again, half-life in the same neighbourhood as sema, so a step change takes about a month to reach steady state. Judging a new step at day five is judging noise.
Tell me where this is wrong. That is the useful part of posting it.
best — the order this archive was captured in
Vials and pens carry the same molecule; what differs is fill volume, device tolerance and whether you are doing your own arithmetic. Neither is inherently more accurate.
Left up, flair changed to Discussion. It is an opinion post and that is fine as long as it is labelled.
Flair corrected to Results, since the body has numbers in it and the title promised them.
I would separate the two claims. That the GIP arm exists is uncontroversial; that it explains your fatigue pattern is a guess.
The thing nobody warned me about was how much of this is logistics — storing it, remembering it, the same day every week.
Did you come to this from sema, and if so how long was the gap?
Careful with "everyone tolerates it better". The people it did not suit stop posting, which makes this board look calmer than the drug is.
Push back: "gentler than sema" is a population statement. Plenty of people on this board have the opposite experience and they are not doing it wrong.
- 1Left up, flair changed to Discussion. It is an opinion post and that is fine…7 comments in this branch · started by u/titration_marshal